Skip to content
Selenious acid
Multrys, Tralement (selenious acid) is a small molecule pharmaceutical. Selenious acid was first approved as Selenious acid on 2019-04-30. It is used to treat deficiency diseases in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
Combinations
Multrys, Tralement
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cupric sulfate
+
Manganese sulfate
+
Selenious acid
+
Zinc sulfate
Tradename
Company
Number
Date
Products
MULTRYSAmerican RegentN-209376 RX2021-06-30
1 products, RLD, RS
TRALEMENTAmerican RegentN-209376 RX2020-07-02
2 products, RLD, RS
Selenious acid
Tradename
Company
Number
Date
Products
SELENIOUS ACIDAmerican RegentN-209379 RX2019-04-30
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
multrysNew Drug Application2021-06-01
selenious acidNew Drug Application2021-08-01
tralementNew Drug Application2020-07-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
deficiency diseasesEFO_1001067D003677E63
Agency Specific
FDA
EMA
Expiration
Code
CUPRIC SULFATE / MANGANESE SULFATE / SELENIOUS ACID / ZINC SULFATE, MULTRYS, AM REGENT
2024-04-30NCE
CUPRIC SULFATE / MANGANESE SULFATE / SELENIOUS ACID / ZINC SULFATE, TRALEMENT, AM REGENT
2024-04-30NCE
SELENIOUS ACID, SELENIOUS ACID, AM REGENT
2024-04-30NCE
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bacterial vaginosisD016585EFO_0003932—231—5
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Trichomonas infectionsD014245DOID_1947A59——1——1
Vaginal dischargeD019522——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Typhoid feverD014435EFO_0006789A01.011———1
CholeraD002771A0011———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GiardiasisD005873DOID_10718A07.1————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSELENIOUS ACID
INN—
Description
Selenous acid is a selenium oxoacid. It is a conjugate acid of a hydrogenselenite.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=[Se](O)O
Identifiers
PDB—
CAS-ID7783-00-8
RxCUI36344
ChEMBL IDCHEMBL2009089
ChEBI ID26642
PubChem CID1091
DrugBankDB11127
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 769 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
222 adverse events reported
View more details